GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Burzynski Research Institute Inc (OTCPK:BZYR) » Definitions » EV-to-FCF

BZYR (Burzynski Research Institute) EV-to-FCF : -15.85 (As of Mar. 04, 2025)


View and export this data going back to . Start your Free Trial

What is Burzynski Research Institute EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Burzynski Research Institute's Enterprise Value is $7.61 Mil. Burzynski Research Institute's Free Cash Flow for the trailing twelve months (TTM) ended in Nov. 2024 was $-0.48 Mil. Therefore, Burzynski Research Institute's EV-to-FCF for today is -15.85.

The historical rank and industry rank for Burzynski Research Institute's EV-to-FCF or its related term are showing as below:

BZYR' s EV-to-FCF Range Over the Past 10 Years
Min: -44.69   Med: 0   Max: 0
Current: -15.85

BZYR's EV-to-FCF is ranked worse than
100% of 419 companies
in the Biotechnology industry
Industry Median: 3.78 vs BZYR: -15.85

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-04), Burzynski Research Institute's stock price is $0.0579. Burzynski Research Institute's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Nov. 2024 was $-0.006. Therefore, Burzynski Research Institute's PE Ratio (TTM) for today is At Loss.


Burzynski Research Institute EV-to-FCF Historical Data

The historical data trend for Burzynski Research Institute's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Burzynski Research Institute EV-to-FCF Chart

Burzynski Research Institute Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.48 -9.68 -12.12 -19.32 -5.77

Burzynski Research Institute Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.05 -5.77 -10.89 -9.86 -9.58

Competitive Comparison of Burzynski Research Institute's EV-to-FCF

For the Biotechnology subindustry, Burzynski Research Institute's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Burzynski Research Institute's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Burzynski Research Institute's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Burzynski Research Institute's EV-to-FCF falls into.



Burzynski Research Institute EV-to-FCF Calculation

Burzynski Research Institute's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=7.610/-0.48
=-15.85

Burzynski Research Institute's current Enterprise Value is $7.61 Mil.
Burzynski Research Institute's Free Cash Flow for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Burzynski Research Institute  (OTCPK:BZYR) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Burzynski Research Institute's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0579/-0.006
=At Loss

Burzynski Research Institute's share price for today is $0.0579.
Burzynski Research Institute's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.006.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Burzynski Research Institute EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Burzynski Research Institute's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Burzynski Research Institute Business Description

Traded in Other Exchanges
N/A
Address
9432 Katy Freeway, Houston, TX, USA, 77055
Burzynski Research Institute Inc operates primarily as a research and development facility of Antineoplaston drugs currently being tested for the use in the treatment of cancer, and provides consulting services.
Executives
Monika Szopa-paszkowiak director 9432 KATY FWY #200, HOUSTON TX 77055
Frederick Richard Schiff director 9432 KATY FREEWAY, HOUSTON TX 77055
Barbara Burzynski director, 10 percent owner 9432 KATY FREEWAY, HOUSTON TX 77055
Carlton Hazlewood director 9432 KATY FREEWAY, HOUSTON TX 77055
Patryk Goscianski officer: Secretary and Treasurer 9432 KATY FREEWAY, HOUSTON TX 77055
Gregory Burzynski director 9432 KATY FREEWAY, HOUSTON TX 77055
Tomasz Janicki officer: VP of Clinical Trials 9432 KATY FREEWAY, HOUSTON TX 77055
Michael Driscoll director 9432 KATY FREEWAY, HOUSTON TX 77055
Stanislaw Burzynski director, 10 percent owner, officer: President 9432 KATY FREEWAY, HOUSTON TX 77055
Dudley Reece Anderson officer: Chief Financial Officer 9432 OLD KATY RD., SUITE 200, HOUSTON TX 77055

Burzynski Research Institute Headlines

No Headlines